What's happening
This bill requires the New York Department of Health to publish annual, publicly accessible reports detailing all opioid sales in the state.
Why it matters
Increases transparency and public oversight. by requiring detailed, company-level opioid sales data—including quantities, strengths, and financial information—to be released in machine-readable formats, enabling researchers, journalists, and advocates to analyze trends and hold manufacturers and distributors accountable.
Allows tracking of opioid distribution patterns. over time and by recipient, providing crucial data to identify potential hotspots of over-prescribing, diversion risks, or emerging public health crises at a granular level.
Backdates initial reporting to mid-2019. , which means the public and policymakers will gain immediate historical context on opioid sales, not just future data, offering insights for policy evaluation and trend analysis.
Facilitates data-driven responses. by empowering local governments, health departments, and community organizations with timely, accessible information to tailor interventions and prevention strategies to areas most affected by opioid sales.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Publish Opioid Sales Data
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Approval memo.70
- Signed chap.771
- Delivered to governor
- Returned to senate
- Passed assembly
- Ordered to third reading cal.391
- Substituted for A8339A
- Referred to health
- Delivered to assembly
- Passed senateVote 62–0
- Advanced to third reading
- 2nd report cal.
Show 5 earlier actions
- 1st report cal.638
- Print number 7378a
- Amend and recommit to budget and revenue
- Referred to budget and revenue
- Referred to rules
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Publish Opioid Sales Reports
Assembly Floor Calendar · Sponsor Jessica Gonzalez-Rojas
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
7378--A
2021-2022 Regular Sessions
IN SENATE
September 15, 2021
Introduced by Sen. HARCKHAM -- read twice and ordered printed, and when printed to be committed to the Committee on Rules -- recommitted to the Committee on Budget and Revenue in accordance with Senate Rule 6, sec. 8 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee
AN ACT to amend the tax law, in relation to requiring the department of health to publish certain reports on department's website detailing sales of opioids sold in the state
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Short title. This act shall be known and may be cited as the "registered opioid sales for transparency and epidemic recovery (ROSTER) act".
§ 2. Subdivision (g) of section 498 of the tax law, as added by section 1 of part XX of chapter 59 of the laws of 2019, is amended to read as follows:
(g) Each registrant shall provide a report to the department of health detailing all opioids sold by such registrant in the state of New York. Such report shall include:
(i) the registrant's name, address, phone number, federal Drug Enforcement Agency (DEA) registration number, education department registration number, and controlled substance license number issued by the department of health, if applicable;
(ii) the name, address and DEA registration number of the entity to whom the opioid was sold;
(iii) the date of the sale of the opioid;
(iv) the gross receipt total, in dollars, for each opioid sold;
(v) the name and National Drug Code of the opioid sold;
(vi) the number of containers and the strength and metric quantity of controlled substance in each container of the opioid sold;
(vii) the total number of morphine milligram equivalents sold; and
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD13199-02-2
(viii) any other elements as deemed necessary by the commissioner of health.
Such information shall be reported and published annually in such form as defined by the commissioner of health and shall not be subject to the provisions of section four hundred ninety-nine of this article, with the exception of paragraph (ii) of this subdivision. The information collected in such report shall be made available to the public in machine-readable formats and such report shall be made publicly available on the department of health's website.
§ 3. Within ninety days of the effective date of this act, the department of health shall compile and publish on its website all reports submitted to the department detailing all opioids sold by a registrant in the state of New York pursuant to subdivision (g) of section 498 of the tax law, including the initial report with transaction information from July 1, 2019 through December 31, 2019 and each annual report thereafter.
§ 4. This act shall take effect immediately.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the tax law, in relation to requiring the department of health to publish certain reports on department's website detailing sales of opioids sold in the state
Purpose
Requires the department of health to publish certain reports on the department's website detailing sales of opioids sold in the state
Summary of provisions
Section 1 titles this act "registered opioid sales for transparency and epidemic recovery (ROSTER) act"
Section 2 amends subdivision (G) of section 498 of the tax law to require that the department of health publish their annual report detailing all opioids sold by such registrants in the state of New York, with the exception of paragraph (ii) of this subdivision. Such report shall be made available to the public in machine-readable formats and such report shall be made publicly available on the department of health's website.
Section 3 requires the department of health to comply and publish on their website all reports submitted to the department detailing all opioids sold by a registrant in the state of New York pursuant to subdi- vision (G) of section 498 of the tax law. This includes the initial report with transaction information from July 1, 2019 through December 31, 2019, and each annual report thereafter.
Section 4 states the effective date.
Justification
The 2019 New York State enacted budget established an "Opioid Steward- ship Fund" to combat the opioid overdose crisis. Financed by an assess- ment on opioid products sold or distributed in New York, the annual $100 million dollar stewardship payments were formulated to place the finan- cial burden of the opioid crisis upon the companies that are making billions in profits. The program's funding was directed to be used for support programs operated by the Office of Addiction Services and Supports (OASAS). Such programs include opioid treatment, recovery, prevention, education, and the I-STOP program, pursuant to the approval of the NYS Budget Director. Included in the creation of the Opioid Stewardship Fund was the requirement for the Department of Health (DOH)to annually gather reports detailing all opioids sold by regis- trants authorized in the state. To date, this information has not been accessible.
This legislation provides transparency to the public regarding the Opioid Stewardship fund by requiring DOH to make the information collected in such reports to be publicly available on the department's website.
Legislative history
This is a new bill.
Fiscal implications
None to the State.
Effective date
This act shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.